Viking Therapeutics (VKTX)'s 30-day implied volatility (IV30) was 60.0% at the close on October 28, 2026, up from 56.8% the day before, against a 52-week range of 45.5% to 126.9%. Its 20-day historical volatility was 59.9%.
Data as of October 28, 2026.